Apoptosis
NF-kappa B overrides apoptotic program of TNFr 1 but not CD40 in carcinoma cells
Published in Gene Therapy Weekly, June 2nd, 2005
According to recent research from England, "The activation of NF-kappa B and phosphatidylinositol-3 (PI3) kinase by TNF-alpha and TRAIL overrides the pro-apoptotic effects of these ligands in carcinoma cells and hinders their therapeutic application.
"In this report we show that CD40 ligand, another member of the TNF superfamily, also triggers the activation of these signaling pathways but, importantly, utilizes only the PI3 kinase cascade for anti-apoptotic responses, inasmuch as suppression of PI3 kinase but not NF-kappa B sensitizes carcinoma cells to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-06-02)
More Articles from Gene Therapy Weekly
- Cancer Therapy
Dual gene-virotherapy eradicates established tumors in animal models - Enzymology
Heparanase gene inhibition crushes melanoma cell invasion mechanisms - Gene Transfer
SIRES bicistronic vectors enable clinicians to monitor therapeutic genes - Oncology
Delta Np73 antisense activates apoptosis in neuroblastoma cells - Vector Development
Semi-replicative virus vectors allay concerns about viral pathogenicity - Acute Myeloid Leukemia
RT-PCR is an early predictive factor of relapse risk in AML with t(8; 21) - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
